We are live on
!
Find out more
AAP
Ardsley Advisory Partners Portfolio holdings
AUM
$960M
1-Year Est. Return
207.76%
This Fund
S&P 500
This Quarter
Est. Return
+5.41%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$642M
AUM Growth
-$1.47M
(-0.23%)
Cap. Flow
-$25M
Cap. Flow
% of AUM
-3.9%
Top 10 Holdings %
Top 10 Hldgs %
34.16%
Holding
208
New
57
Increased
39
Reduced
29
Closed
72
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$20.3M |
| 2 |
SSNI
Silver Spring Networks, Inc.
SSNI
|
+$9.55M |
| 3 |
NSM
Nationstar Mortgage Holdings
NSM
|
+$9.31M |
| 4 |
United Rentals
URI
|
+$8.93M |
| 5 |
AY
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
|
+$7.87M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SHPG
Shire pic
SHPG
|
+$15.6M |
| 2 |
PEGI
Pattern Energy Group Inc. Class A
PEGI
|
+$14.8M |
| 3 |
AKRX
Akorn Inc
AKRX
|
+$12.2M |
| 4 |
STKL
SunOpta
STKL
|
+$10.5M |
| 5 |
Hannon Armstrong Sustainable Infrastructure Capital
HASI
|
+$9.49M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.46% |
| 2 | Healthcare | 11.72% |
| 3 | Financials | 7.78% |
| 4 | Utilities | 6.79% |
| 5 | Materials | 5.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Gen Digital
GEN
$16.6B
| $424K | 0.07% |
+15,000
| New | +$454K |
|
102
Cigna
CI
$79.6B
| $418K | 0.07% |
+2,500
| New | +$402K |
|
103
Aclaris Therapeutics
ACRS
$744M
| $407K | 0.06% |
+15,000
| New | +$408K |
|
|
ATVI
104
DELISTED
Activision Blizzard
ATVI
| $403K | 0.06% |
+7,000
| New | +$387K |
|
|
BOLD
105
DELISTED
Audentes Therapeutics, Inc
BOLD
| $384K | 0.06% |
20,072
+7,500
| +60% | +$120K |
|
106
Abeona Therapeutics
ABEO
$343M
| $383K | 0.06% |
2,400
+600
| +33% | +$81.9K |
|
107
AtriCure
ATRC
$2.01B
| $364K | 0.06% |
15,000
-4,000
| -21% | -$85K |
|
|
TWTR
108
DELISTED
Twitter, Inc.
TWTR
| $357K | 0.06% |
20,000
+10,000
| +100% | +$170K |
|
|
OXFD
109
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $336K | 0.05% |
20,000
-10,000
| -33% | -$149K |
|
110
MACOM Technology Solutions
MTSI
$19B
| $335K | 0.05% |
+6,000
| New | +$324K |
|
111
Novartis
NVS
$304B
| $334K | 0.05% |
+4,464
| New | +$316K |
|
112
Incyte
INCY
$26B
| $315K | 0.05% |
2,500
-1,000
| -29% | -$127K |
|
113
Advanced Micro Devices
AMD
$741B
| $312K | 0.05% |
+25,000
| New | +$306K |
|
|
JUNO
114
DELISTED
Juno Therapeutics, Inc.
JUNO
| $299K | 0.05% |
+10,000
| New | +$247K |
|
|
NVTR
115
DELISTED
Nuvectra Corporation Common Stock
NVTR
| $293K | 0.05% |
22,095
-5,000
| -18% | -$47.4K |
|
116
Viatris
VTRS
$20.8B
| $291K | 0.05% |
+7,500
| New | +$288K |
|
|
DERM
117
DELISTED
Dermira, Inc.
DERM
| $291K | 0.05% |
+10,000
| New | +$304K |
|
|
CBAY
118
DELISTED
Cymabay Therapeutics
CBAY
| $290K | 0.05% |
50,210
+20,000
| +66% | +$85.1K |
|
|
EXAS
119
DELISTED
Exact Sciences
EXAS
| $265K | 0.04% |
7,500
-225,000
| -97% | -$6.94M |
|
|
PRTK
120
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $265K | 0.04% |
11,000
-5,000
| -31% | -$111K |
|
|
ADMS
121
DELISTED
Adamas Pharmaceuticals
ADMS
| $262K | 0.04% |
15,000
| – | – |
|
122
Neurocrine Biosciences
NBIX
$18.4B
| $230K | 0.04% |
+5,000
| New | +$243K |
|
|
TLGT
123
DELISTED
Teligent, Inc
TLGT
| $229K | 0.04% |
2,500
| – | – |
|
|
AKAO
124
DELISTED
Achaogen Inc
AKAO
| $217K | 0.03% |
+10,000
| New | +$228K |
|
|
ZGNX
125
DELISTED
Zogenix, Inc.
ZGNX
| $217K | 0.03% |
15,000
-5,000
| -25% | -$62.8K |
|
Similar funds
NA
MK
QIM
JVBC
TFP
UWPG
LOAMU
PHS
Ardsley Advisory Partners's Q2 2017 Portfolio in Review
As of Q2 2017, Ardsley Advisory Partners held 208 positions worth $642M, down 0.23% from $644M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Ardsley Advisory Partners withdrew a net $25M in Q2 2017, closing 72 positions and reducing 29 holdings. Its most notable exit was Akorn Inc, an estimated $12.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 10% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Ardsley Advisory Partners opened a new position in Nationstar Mortgage Holdings worth $9.84M.
- Ardsley Advisory Partners's largest Q2 2017 buy was Nationstar Mortgage Holdings: 550,000 shares worth $9.84M.
- Ardsley Advisory Partners added most to Alexion Pharmaceuticals in Q2 2017, an estimated $20.3M increase.
- Ardsley Advisory Partners's biggest Q2 2017 reduction was Shire pic, cutting an estimated $15.6M.
- Ardsley Advisory Partners fully exited Akorn Inc in Q2 2017, selling an estimated $12.2M.
- Ardsley Advisory Partners's ten largest holdings make up 34% of its $642M portfolio in Q2 2017.
- Ardsley Advisory Partners opened 57 new positions and closed 72 in Q2 2017.
- Ardsley Advisory Partners's portfolio value fell 0.23% quarter-over-quarter to $642M.
Based on Ardsley Advisory Partners's 13F filing for Q2 2017, filed 14 Aug 2017.